Evidence map›Paper›PMID 32758363›Full record

ReviewDisease-a-month : DM2020

COVID-19 Extrapulmonary illness - The Impact of COVID-19 on Nephrology care.

Dhwanil Patel, Tiffany Truong, Nikhil Shah, Gates B Colbert, Beje Thomas, Juan Carlos Q Velez, Edgar V Lerma, Swapnil Hiremath

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Disease-a-month : DM, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dhwanil PatelNew York University School of Medicine, New York, NY, United States.
Tiffany TruongDivision of Nephrology, Keck School of Medicine of USC and Los Angeles County, USC Medical Center, Los Angeles, CA, United States.
Nikhil ShahDivision of Nephrology and Immunology, University of Alberta, Edmonton, Canada.
Gates B ColbertTexas A&M College of Medicine at Dallas, Dallas, Texas, United States.
Beje ThomasMedStar Georgetown Transplant Institute, Washington, DC, United States. Electronic address: beje.thomas@gunet.georgetown.edu.
Juan Carlos Q VelezDepartment of Nephrology, Ochsner Clinic Foundation, New Orleans, LA, United States.
Edgar V LermaUniversity of Illinois at Chicago College of Medicine/ Advocate Christ Medical Center, Oak Lawn, IL, United States.
Swapnil HiremathUniversity of Ottawa, Ottawa, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease-2019 (COVID-19) has caused a pandemic that has affected millions of people worldwide. COVID-19 is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and is spread by close contact and by respiratory droplets. It has also impacted different aspects of caring for people with kidney disease, including those with acute kidney injury (AKI), chronic kidney disease (CKD), those requiring kidney replacement therapy (KRT), and those with a kidney transplant. All of these patients are considered high risk. The lessons learned from the COVID-19 pandemic will hopefully serve to protect patients with kidney disease in a similar situation in the future.

Indexed as

COVID-19HumansKidney DiseasesNephrologyRenal Replacement TherapySARS-CoV-2

Identifiers

PMID32758363
PMCPMC7381936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.